May 30, 2025 08:11 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Operation Sindoor is not yet over, it's just a pause: Rajnath Singh | Army reduced terrorist hideouts to ruins: PM Modi on Operation Sindoor in Bihar | Prosperity came to Jammu and Kashmir after Article 370 abrogation: Salman Khurshid hails Modi govt's historic step | 'Disappointed': Shashi Tharoor on Colombia's condolence message for Pak deaths in Operation Sindoor | Nine tourists go missing after bus falls into swollen Teesta river in Sikkim | US Judge extends order blocking Trump ban on foreign students' enrolment in Harvard | India rejects Team Trump's latest claim on tariffs' role behind ceasefire with Pakistan | Operation Sindoor is not over yet: PM Modi's announcement from Bengal | 'Why aren't you giving sindoor to your wife first?': Mamata slams Modi on Operation Sindoor | Murshidabad and Malda communal violence reflect TMC govt's cruelty: Modi in Bengal
Covishield

SII to supply 90 to 100 million Covishield doses in June: Report

| @indiablooms | May 31, 2021, at 03:28 am

Pune/IBNS: The Serum Institute of India (SII) has said it will be able to manufacture and supply 90 to 100 million doses of Covishield in June, media reports said.

SII has informed the government that it has ramped up its production capacity and will be able to supply nine to 10 crore doses of Covishield in June as compared to 6.5 crore in May.

Several states, including Punjab, Kerala, Maharashtra, Punjab, Andhra Pradesh, Rajasthan, Uttarakhand and Karnataka, among others, have invited global tenders for Covid-19 vaccines as shortage of jabs forced states to suspend vaccination centres.

SII on Sunday informed the government that its production capacity will be increased to 65 million in June, 70 million in July and 100 million in August.

The Union Health ministry on Sunday said that so far 212 million doses have been administered across the country.

Since May 1, 18.3 million people in the afe group 18-44 have been vaccinated.

India is currently using Bharat Biotech'Covaxin and Serum Institute of India manufactured Covishield, while Russia's Sputnik V is tge third vaccine which has recived approval for use in the country.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu